Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On September 2, 2020, Blonder Tongue Laboratories, Inc. (the "Company") entered into Deferred Compensation Agreements (the "Agreements") with certain of its executive officers (each, an "Executive," and together, the "Executives"), which Agreements provide for the deferral of certain compensation otherwise payable by the Company to each Executive. Under the terms of the Agreements, each Executive agreed to the deferral of a specified percentage of the cash compensation to be earned by such Executive for a specified period of time, measured from September 2, 2020.

As of each date on which compensation that would otherwise have been paid is deferred pursuant to each Executive's Agreement, the Company will accrue a number of shares of its common stock calculated by dividing (i) the dollar amount of the deferred compensation for such date by (ii) the fair market value of one share of the Company's common stock (the "Accrued Shares"). For purposes of calculating the number of Accrued Shares, "fair market value" will equal the official closing price on the NYSE American consolidated tape on the calculation date, or if that day in not a trading day on the trading day immediately preceding such day, as long as the Company's common stock is listed on the NYSE American exchange). On or before March 15, 2021, the Company is obligated to deliver to each Executive the number of Accrued Shares applicable to such Executive, subject to compliance with applicable tax withholding obligations. The Executives, their positions with the Company and details regarding the percentage deferred and deferral period are provided below:





Name and Title                                     Percentage           Deferral Period
Edward R. Grauch                                         5%                09/02/2020 -
President, Chief Executive Officer                                         12/12/2020
Eric Skolnik                                             5%               09/02/2020 -
Senior Vice President, Chief Financial                                     12/12/2020

Officer


Ronald V. Alterio                                        5%               09/02/2020 -
Senior Vice President-Engineering, Chief                                   12/12/2020
Technology Officer
Allen Horvath                                            25%               09/02/2020 -
Senior Vice President-Operations, Asst.                                    12/12/2020

Secretary

The foregoing summary of the Agreements does not purport to be complete and is qualified in its entirety by reference to the full text of the form of Deferred Compensation Agreement, which is attached hereto as Exhibit 10.1 and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits. The following exhibit is filed herewith:





Exhibit No.   Description

   10.1         Form of Deferred Compensation Agreement.



                                       1

© Edgar Online, source Glimpses